BICO’s group companies CELLINK and CYTENA win five German Design Awards for excellent product design
Five products from BICO, the global Bio Convergence company, has been awarded with the prestigious 2022 German Design Awards.
The recognition comes from the widely respected German Design Council and include awards and special mentions for devices from BICO’s group companies, CELLINK and CYTENA. The awards will be officially presented at the German Design Award show in February 2022.
Markus Grip, Global Head of Design, BICO: “Today’s lab instrument is often technical and hard to use, without logical user interfaces and workflows. This incredible recognition proves that researchers conducting work that save lives can benefit from user-friendly instruments with the latest technology with a bold design.”
All the awards come in the Excellent Product Design – Medical, Rehabilitation and Healthcare category and include:
Award Winners
BIO X6 – a 3D bioprinter with six independent printheads to enable high precision and versatile tissue engineering
S.NEST – a next-generation micro bioreactor that enables high-throughput cell line development through the use of temperature control, CO2 adjustability, humidity monitoring, and UV sterilization
C.WASH – a plate washer that uses centrifugal forces to enable automated, rapid, and highly reproducible washing of entire 96-, 384-, and 1,536-well plates
Special Mentions
CELLCYTE X – a live cell imager that enables real-time monitoring and analysis of biological samples using advanced imagery and florescence sensors
UP.SIGHT – a cell line development platform that enables automated single-cell dispensing and imaging to ensure a >99.99% probability of clonality
The award is presented by the German Design Council, one of the world’s competence centres in brand and design.
Established on the initiative of the German Bundestag (the lower house of German parliament) as a foundation in 1953, it supports the industry and are aimed at highlighting added brand value through design.
This comes after a pivotal year for BICO after it added seven companies to its group and surpassed 1,000+ employees globally.
The company also continued its explosive commercial growth with now having more 25,000 instruments in the labs of the world’s leading life science organizations including Johnson & Johnson, AstraZeneca, Merck, Roche, Amgen, Novartis, Genentech, Harvard University, and others.
